LETTERHEAD]Option Agreement • April 9th, 1999 • Peptide Therapeutics Group PLC • Pharmaceutical preparations
Contract Type FiledApril 9th, 1999 Company IndustryThis letter is intended to outline the general terms which have been agreed between Peptide Therapeutics ("PT") and the joint ventures between OraVax, Inc. and Pasteur Merieux Serums et Vaccins S.A. known as Merieux OraVax S.N.C. and OraVax Merieux Co. ("PM-O").
NOVARTIS PHARMA AG COLLABORATION AGREEMENTCollaboration Agreement • April 9th, 1999 • Peptide Therapeutics Group PLC • Pharmaceutical preparations • England and Wales
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
EXHIBIT 10.4 COLLABORATIVE RESEARCH AND OPTION AGREEMENT This COLLABORATIVE RESEARCH AND OPTION AGREEMENT is entered into as of December 22, 1997 by and between PFIZER INC., a Delaware corporation, having an office at 235 East 42nd Street, New York,...Collaborative Research and Option Agreement • April 9th, 1999 • Peptide Therapeutics Group PLC • Pharmaceutical preparations • England
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
CONFIDENTIALR&d and License Agreement • April 9th, 1999 • Peptide Therapeutics Group PLC • Pharmaceutical preparations • England
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
ARTICLE I COVENANTS, REPRESENTATIONS AND ACKNOWLEDGEMENTS OF LIMITEDOverview Agreement • April 9th, 1999 • Peptide Therapeutics Group PLC • Pharmaceutical preparations • New York
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction
and-Assignment and Variation Agreement • April 9th, 1999 • Peptide Therapeutics Group PLC • Pharmaceutical preparations • Maryland
Contract Type FiledApril 9th, 1999 Company Industry Jurisdiction